SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Multiple Sclerosis and Related Disorders

Submit
Log in
Register
Log in
- Submit
- Log in
Subscribe
Claim

Skip menu

Articles
- Latest
- Popular Articles
  
  Review article
  Open Access
  Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases
  Wildner et al.
  Review article
  Open Access
  Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
  Oreja-Guevara et al.
  Editorial
  Long COVID or post COVID-19 syndrome
  Lechner-Scott et al.
- Latest Articles
  Review article
  Disease-modifying therapy for multiple sclerosis: implications for gut microbiota
  Silvy et al.
  Original article
  Sexual Problems in MS: Sex Differences and Their Impact on Quality of Life
  Kaplan et al.
  Research Article
  Clinical and fringe benefits of rituximab in multiple sclerosis treatment in a poor resource setting: Case series and cost analysis
  Aungsumart et al.
Publish
- For Authors
Topics
- - MENACTRIMS Congresses
About
- Journal Information
- Access
  - Subscribe
  - Activate Online Access
Contact
- Contact
- Follow Us
  - New Content Alerts
  - Facebook
    External Link

Advanced search

Please enter a term before submitting your search.

November 2021

Volume 56

Current Issue
Issues in Progress
Articles in Press
Archive
- Articles in Press
- Archive

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Original Articles

The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment

H.Phuong T. Pham,
Resmi Gupta,
J. William Lindsey

Published online: September 27, 2021

103282

Full-Text HTML
PDF

Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis

Marja Niiranen,
Aleksi Kontkanen,
Olli Jääskeläinen,
...
Sanna-Kaisa Herukka,
Sakari Simula,
Anne M. Remes

Published online: September 27, 2021

103280

Full-Text HTML
PDF

Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study

Niklas Frahm,
David Ellenberger,
Firas Fneish,
...
Alexander Stahmann,
Vroni Vogelmann,
Peter Flachenecker

Published online: September 26, 2021

103281

Open Access

Full-Text HTML
PDF
Supplemental Materials

Vitamin D status, proinflammatory cytokines and bone mineral density in Mexican people with multiple sclerosis

Ana Laura Hernández-Ledesma,
Adriana Jheny Rodríguez-Méndez,
Lilia Susana Gallardo-Vidal,
...
María Elena Villagrán-Herrera,
Ma. Guadalupe Martínez-Peña,
Teresa García-Gasca

Published online: September 15, 2021

103265

Full-Text HTML
PDF

Patients’ experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis

Charlotte R. Wicks,
Rob Sloan,
Sophie DiMauro,
...
Sam Billington,
Mark Webb,
George Pepper

Published online: September 15, 2021

103259

Full-Text HTML
PDF

Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case report

Monica Marta,
David Baker,
Paul Creeke,
Gareth Pryce,
Sharmilee Gnanapavan,
Gavin Giovannoni

Published online: September 30, 2021

103284

Full-Text HTML
PDF
Supplemental Materials

Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis

Daniel Jons,
Linn Persson Berg,
Peter Sundström,
...
Måns Thulin,
Tomas Bergström,
Oluf Andersen

Published online: September 27, 2021

103288

Open Access

Full-Text HTML
PDF
Supplemental Materials

Sociodemographic and clinical characteristics of diet adherence and relationship with diet quality in an international cohort of people with multiple sclerosis

Steve Simpson-Yap,
Nupur Nag,
Mohamed Jakaria,
George A Jelinek,
Sandra Neate

Published online: October 03, 2021

103307

Open Access

Full-Text HTML
PDF
Supplemental Materials

Retinal microvascular and neuronal function in patients with multiple sclerosis: 2-year follow-up

Qi Chen,
Min Fang,
Shahnaz Miri,
...
Vittorio Porciatti,
Jianhua Wang,
Hong Jiang

Published online: October 04, 2021

103314

Full-Text HTML
PDF

Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder

Smathorn Thakolwiboon,
Hannah Zhao-Fleming,
Amputch Karukote,
Yang Mao-Draayer,
Eoin P. Flanagan,
Mirla Avila

Published online: October 04, 2021

103310

Full-Text HTML
PDF
Supplemental Materials

Predictors of cognitive fatigue and fatigability in multiple sclerosis

Leila Mackay,
Andrew M. Johnson,
Sheila T. Moodie,
Heather Rosehart,
Sarah A. Morrow

Published online: October 06, 2021

103316

Full-Text HTML
PDF

The relationship between plantar sensation and muscle onset during automatic postural responses in people with multiple sclerosis and healthy controls

A.S. Monaghan,
J.M. Huisinga,
D.S. Peterson

Published online: October 04, 2021

103313

Full-Text HTML
PDF

Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients

Moogeh Baharnoori,
Ryan Wilson,
Shrishti Saxena,
...
Kiandokht Keyhanian,
Brian C. Healy,
Tanuja Chitnis

Published online: October 04, 2021

103311

Full-Text HTML
PDF
Supplemental Materials

COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register

RM Middleton,
EM Craig,
WJ Rodgers,
...
J Taylor,
R Nicholas
UK Multiple Sclerosis Register Research Group

Published online: October 07, 2021

103317

Open Access

Full-Text HTML
PDF

The MuSC-19 study: The Egyptian cohort

Magd Zakaria,
Marta Ponzano,
Irene Schiavetti,
...
Sandra Ahmed,
Mohamed Foad,
Maria Pia Sormani

Published online: October 10, 2021

103324

Full-Text HTML
PDF

Application of definitions for conversion to secondary progressive MS in a Danish nationwide population

Tine Iskov Kopp,
Stephan Bramow,
Zsolt Illes,
...
Peter Vestergaard Rasmussen,
Finn Sellebjerg,
Melinda Magyari

Published online: October 09, 2021

103319

Open Access

Full-Text HTML
PDF

Sociodemographic and clinical factors associated with depression, anxiety, and general mental health in people with multiple sclerosis during the COVID-19 pandemic

Lauren Uhr,
Dylan R. Rice,
Farrah J. Mateen

Published online: October 11, 2021

103327

Full-Text HTML
PDF
Supplemental Materials

Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis

Helene Højsgaard Chow,
Jacob Talbot,
Lisbet Marstrand,
...
Hartwig Roman Siebner,
Helle Bach Søndergaard,
Finn Sellebjerg

Published online: October 09, 2021

103296

Open Access

Full-Text HTML
PDF
Supplemental Materials

$Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS$

Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS

Ahmed M. Elkady,
Zhe Wu,
Ilana R. Leppert,
Douglas L. Arnold,
Sridar Narayanan,
David A. Rudko

Published online: October 04, 2021

103309

Full-Text HTML
PDF

Correspondence

Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis

G. Ben Noon,
I. Vigiser,
T. Shiner,
H. Kolb,
A. Karni,
K. Regev

Published online: August 17, 2021

103220

Full-Text HTML
PDF

The investigation of the cerebral venous system in multiple sclerosis

Clive Beggs,
Paolo Zamboni

Published online: August 31, 2021

103234

Full-Text HTML
PDF

Dosing schedules for Ofatumumab in multiple sclerosis: Overegging the pudding

Jagannadha Avasarala,
Patricia A Olson

Published online: September 03, 2021

103250

Full-Text HTML
PDF

Genetically predicted circulating homocysteine, vitamin B12, and folate levels and risk of multiple sclerosis: evidence from a two-sample Mendelian randomization analysis

Haoxin Peng,
Xiangrong Wu,
Jinsheng Lin,
Wenhui Guan

Published online: September 05, 2021

103255

Full-Text HTML
PDF
Supplemental Materials

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed

Abdorreza Naser Moghadasi

Published online: September 13, 2021

103263

Full-Text HTML
PDF

Methylphenidate may improve mental fatigue in individuals with multiple sclerosis: A pilot clinical trial

J.Y. Natsheh,
J. DeLuca,
S.L. Costa,
N.D. Chiaravalloti,
E. Dobryakova

Published online: September 20, 2021

103273

Full-Text HTML
PDF

Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes

Emily Kamma,
Pierre Becquart,
Anthony Traboulsee,
...
Cornelia Laule,
Carles Vilariño-Güell,
Jacqueline A. Quandt

Published online: September 18, 2021

103269

Full-Text HTML
PDF

Multiple sclerosis in Sri Lanka; epidemiology, demographic patterns and current trends

Bimsara Senanayake,
Mythily Aravinthan,
Sandun Weerasinghe,
Rasika De Silva

Published online: September 21, 2021

103276

Full-Text HTML
PDF

Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample Mendelian randomization analysis

Haoxin Peng,
Xiangrong Wu,
Yaokai Wen,
Jinsheng Lin

Published online: September 21, 2021

103267

Full-Text HTML
PDF
Supplemental Materials

Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19⁺ B-cell repopulation

Nitin Kumar Sahi,
Syed Muhammad Ali Abidi,
Omar Salim,
Roby Abraham,
Seema Kalra,
Adnan Al-Araji

Published online: September 27, 2021

103287

Full-Text HTML
PDF

Isolated cognitive syndrome is a prodromal presentation of multiple sclerosis

Vladimiro Sinay

Published online: October 04, 2021

103315

Full-Text HTML
PDF

Infection incidence and management in multiple sclerosis patients after initiating disease-modifying therapy

Elizabeth C.S. Swart,
Douglas Mager,
Natasha Parekh,
...
Kiraat Munshi,
Gail Bridges,
Chester B. Good

Published online: September 27, 2021

103285

Full-Text HTML
PDF
Supplemental Materials

Results per page:50

Login to your account

Email/Username

Password

Show

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel

Home
Articles & Issues
Articles In Press
Current Issue
List of Issues
Collections
Editor's Choice
MS Special Issues
MENACTRIMS Congresses
For Authors
Author Information
Open Access Options
Permissions
Researcher Academy
Submit a Manuscript
Journal Info
About the Journal
About Open Access
Abstracting/Indexing
Activate Online Access
Career Opportunities
Contact Information
Editorial Board
Pricing
Reprints
New Content Alerts
Subscribe
More Periodicals
Find a Periodical
Go to Product Catalog
Follow Us
Facebook

The content on this site is intended for healthcare professionals.

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

Popular Articles

November 2021

Original Articles

Correspondence